DANIELLE SIMPSON: Open Payments
NPI 1063947737 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $46 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $67 |
| Teva Pharmaceuticals USA, Inc. | 2 | $62 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Alkermes, Inc. | 1 | $23 |
Products named: INVEGA SUSTENNA, UZEDY, INGREZZA, VRAYLAR, COBENFY, ARISTADA.
Industry payments across PA — which companies pay providers there.
